Apollo Endosurgery Inc (APEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,301 | -6,565 | -5,161 | -2,632 | -1,250 |
| Depreciation Amortization | 36 | 196 | 162 | 129 | 42 |
| Accounts receivable | -1,394 | -1,076 | -388 | -149 | 6 |
| Other Working Capital | -1,169 | -6,577 | -4,949 | -3,964 | -2,756 |
| Other Operating Activity | 1,907 | 872 | 982 | -236 | -41 |
| Operating Cash Flow | $-3,921 | $-13,149 | $-9,355 | $-6,851 | $-3,999 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -91 | -45 | -38 | -38 | -11 |
| Purchase Sale Intangibles | -99 | -346 | -272 | -186 | -74 |
| Other Investing Activity | -99 | -346 | -272 | -186 | -74 |
| Investing Cash Flow | $-190 | $-391 | $-310 | $-223 | $-85 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,441 | 818 | 3 | 3 | 2 |
| Other Financing Activity | -71 | -48 | -45 | -45 | 0 |
| Financing Cash Flow | $8,370 | $771 | $-42 | $-42 | $2 |
| Beginning Cash Position | 11,852 | 24,621 | 24,621 | 24,621 | 24,621 |
| End Cash Position | 16,111 | 11,852 | 14,915 | 17,506 | 20,538 |
| Net Cash Flow | $4,260 | $-12,769 | $-9,706 | $-7,115 | $-4,083 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,921 | -13,149 | -9,355 | -6,851 | -3,999 |
| Capital Expenditure | -91 | -45 | -38 | -38 | -11 |
| Free Cash Flow | -4,012 | -13,194 | -9,393 | -6,888 | -4,010 |